In a patient with a history of organophosphorus poisoning scheduled for general anesthesia, what precautions and management should be undertaken?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Anesthetic Management of Patients with Prior Organophosphorus Poisoning

Direct Recommendation

Avoid succinylcholine entirely in patients with prior organophosphorus poisoning, use rocuronium (0.6 mg/kg or slightly higher) for intubation instead, and check pseudocholinesterase levels preoperatively regardless of time elapsed since exposure. 1, 2

Preoperative Assessment and Precautions

Mandatory Laboratory Testing

  • Measure pseudocholinesterase levels preoperatively, irrespective of duration post-exposure 2
    • A case report demonstrated prolonged 3-hour apnea occurring 38 days after organophosphorus exposure despite using reduced succinylcholine dose (<0.3 mg/kg) 2
    • In strong suspects, also measure dibucaine number and fluoride number 2
    • Acetylcholinesterase activity in blood should be assessed if available 1

Clinical History Assessment

  • Document time since organophosphorus exposure 1, 3
  • Assess for delayed complications including:
    • Intermediate syndrome (can occur up to 4 days post-exposure) 1
    • Delayed polyneuropathy 3
    • Vocal cord paralysis history 3
    • Neuropsychiatric disorders 3

Intraoperative Management

Muscle Relaxant Selection

Completely avoid succinylcholine and mivacurium due to:

  • Prolonged inhibition of plasma cholinesterase by organophosphorus compounds 1, 3
  • Unpredictable and potentially life-threatening prolonged paralysis 2

Use rocuronium as the preferred agent:

  • Dose: 0.6 mg/kg or slightly above normal intubation dosage 1
  • Advantages: mild vagolytic effect and lacks acetylcholinesterase-dependent metabolism 1
  • Provides reliable intubating conditions without cholinesterase-dependent degradation 1

Monitoring Considerations

  • Neuromuscular function monitoring is essential throughout the case 1
  • Be aware that altered responses to non-depolarizing neuromuscular blockers may occur due to acetylcholinesterase inhibition causing neuromuscular junction dysfunction 3

Airway Management

  • Anticipate excessive secretions requiring aggressive suctioning 1, 4
  • Ensure adequate atropinization if needed for secretion control 4

Postoperative Management

Critical Extubation Criteria

Do not extubate until ALL of the following are met:

  • Patient is fully awake 1
  • Clear of secretions 1
  • Upper airway reflexes are intact 1
  • Adequate spontaneous ventilation without difficulty 1

High-Risk Complications to Monitor

Delayed Respiratory Failure (Most Critical):

  • Prolonged muscle weakness can occur up to 4 days after acute exposure 1
  • Residual neuromuscular blockade affects tongue, pharynx, and laryngeal muscles 1
  • Bilateral recurrent laryngeal nerve paralysis causing delayed asphyxia has been reported 1
  • This delayed paralysis barely responds to antidotal treatment 1
  • If delayed weakness occurs, provide supportive mechanical ventilation in ICU for several days as needed 1

Rhabdomyolysis and Renal Complications:

  • Severe myonecrosis can develop from excessive acetylcholine accumulation causing calcium overload in skeletal muscle 1
  • Monitor serum creatine kinase and potassium levels closely 1
  • Watch for reddish urine indicating myoglobinuria 1
  • Treatment: adequate hydration, forced diuresis, and urine alkalinization 1

Ventilatory Support Considerations

  • CPAP ventilation may be suboptimal in post-surgical patients with full stomach or bowel paralysis 1
  • Prepare for potential prolonged mechanical ventilation requirements 1, 5
  • Early recognition of respiratory distress (respiratory rate increasing from 22 to 38 breaths/min is an important warning sign) 5

Common Pitfalls to Avoid

  1. Never rely on time elapsed since exposure alone - pseudocholinesterase levels remain unpredictably low for extended periods 2
  2. Do not assume 4-week waiting period is sufficient - the traditional 4-week recommendation is inadequate without biochemical confirmation 2
  3. Avoid delayed intubation in respiratory distress - early recognition and intervention is life-saving 5
  4. Do not use reduced-dose succinylcholine as a "safer" alternative - even minimal doses can cause prolonged apnea 2

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.